Ampicillin	Ampicillin	NN	B-NP	B-protein		0	10
-	-	HYPH	I-NP	O		10	11
resistant	resistant	JJ	I-NP	O		11	20
Haemophilus influenzae	Haemophilus_influenzae	NNP	I-NP	O		21	43
type	type	NN	I-NP	O		44	48
B	B	NN	I-NP	O		49	50
possessing	possess	VBG	B-VP	O		51	61
a	a	DT	B-NP	O		62	63
TEM	TEM	NN	I-NP	B-protein		64	67
-	-	HYPH	I-NP	I-protein		67	68
type	type	NN	I-NP	I-protein		68	72
beta	beta	SYM	O	I-protein		73	77
-	-	HYPH	O	I-protein		77	78
lactamase	lactamase	NN	B-NP	I-protein		78	87
but	but	CC	O	O		88	91
little	little	JJ	B-NP	O		92	98
permeability	permeability	NN	I-NP	O		99	111
barrier	barrier	NN	I-NP	O		112	119
to	to	TO	B-PP	O		120	122
ampicillin	ampicillin	NN	B-NP	B-protein		123	133
.	.	.	O	O		133	134

Ampicillin	Ampicillin	NN	B-NP	B-protein		135	145
-	-	HYPH	I-NP	O		145	146
resistant	resistant	JJ	I-NP	O		146	155
Haemophilus influenzae	Haemophilus_influenzae	NNP	I-NP	O		156	178
type	type	NN	I-NP	O		179	183
B	B	NN	I-NP	O		184	185
have	have	VBP	B-VP	O		186	190
been	be	VBN	I-VP	O		191	195
reported	report	VBN	I-VP	O		196	204
only	only	RB	B-ADVP	O		205	209
during	during	IN	B-PP	O		210	216
the	the	DT	B-NP	O		217	220
past	past	JJ	I-NP	O		221	225
year	year	NN	I-NP	O		226	230
.	.	.	O	O		230	231

Five	Five	CD	B-NP	O		232	236
clinical	clinical	JJ	I-NP	O		237	245
isolates	isolate	NNS	I-NP	O		246	254
from	from	IN	B-PP	O		255	259
the	the	DT	B-NP	O		260	263
U.S.	U.S.	NNP	I-NP	O		264	268
and	and	CC	I-NP	O		269	272
Germany	Germany	NNP	I-NP	O		273	280
all	all	DT	O	O		281	284
had	have	VBD	B-VP	O		285	288
the	the	DT	B-NP	O		289	292
TEM	TEM	NN	I-NP	B-protein		293	296
-	-	HYPH	O	I-protein		296	297
type	type	NN	B-NP	I-protein		297	301
beta	beta	SYM	I-NP	I-protein		302	306
-	-	HYPH	I-NP	I-protein		306	307
lactamase	lactamase	NN	I-NP	I-protein		307	316
which	which	WDT	B-NP	O		317	322
is	be	VBZ	B-VP	O		323	325
known	know	VBN	I-VP	O		326	331
to	to	TO	I-VP	O		332	334
be	be	VB	I-VP	O		335	337
transferred	transfer	VBN	I-VP	O		338	349
widely	widely	RB	B-ADVP	O		350	356
among	among	IN	B-PP	O		357	362
other	other	JJ	B-NP	O		363	368
gram	gram	NN	I-NP	O		369	373
-	-	HYPH	B-NP	O		373	374
negative	negative	JJ	I-NP	O		374	382
bacilli	bacilli	NNS	I-NP	O		383	390
.	.	.	O	O		390	391

Unlike	Unlike	IN	B-PP	O		392	398
those	those	DT	B-NP	O		399	404
bacilli	bacilli	NNS	I-NP	O		405	412
,	,	,	O	O		412	413
however	however	RB	B-ADVP	O		414	421
,	,	,	O	O		421	422
the	the	DT	B-NP	O		423	426
H. influenzae	H._influenzae	NNP	I-NP	O		427	440
cell	cell	NN	I-NP	O		441	445
had	have	VBD	B-VP	O		446	449
very	very	RB	B-NP	O		450	454
little	little	JJ	I-NP	O		455	461
barrier	barrier	NN	I-NP	O		462	469
to	to	TO	B-PP	O		470	472
entry	entry	NN	B-NP	O		473	478
of	of	IN	B-PP	O		479	481
penicillins	penicillin	NNS	B-NP	B-protein		482	493
.	.	.	O	O		493	494

This	This	DT	B-NP	O		495	499
greater	great	JJR	I-NP	O		500	507
permeability	permeability	NN	I-NP	O		508	520
of	of	IN	B-PP	O		521	523
the	the	DT	B-NP	O		524	527
H. influenzae	H._influenzae	NNP	I-NP	O		528	541
cell	cell	NN	I-NP	O		542	546
to	to	TO	B-PP	O		547	549
penicillins	penicillin	NNS	B-NP	O		550	561
appeared	appear	VBD	B-VP	O		562	570
to	to	TO	I-VP	O		571	573
reduce	reduce	VB	I-VP	O		574	580
the	the	DT	B-NP	O		581	584
protective	protective	JJ	I-NP	O		585	595
effect	effect	NN	I-NP	O		596	602
of	of	IN	B-PP	O		603	605
its	its	PRP$	B-NP	O		606	609
beta	beta	SYM	I-NP	O		610	614
-	-	HYPH	I-NP	O		614	615
lactamase	lactamase	NN	I-NP	O		615	624
,	,	,	O	O		624	625
in	in	IN	B-PP	O		626	628
that	that	DT	B-NP	O		629	633
acquisition	acquisition	NN	I-NP	O		634	645
of	of	IN	B-PP	O		646	648
the	the	DT	B-NP	O		649	652
TEM	TEM	NN	I-NP	B-protein		653	656
-	-	HYPH	O	I-protein		656	657
type	type	NN	B-NP	I-protein		657	661
beta	beta	SYM	I-NP	I-protein		662	666
-	-	HYPH	I-NP	I-protein		666	667
lactamase	lactamase	NN	I-NP	I-protein		667	676
increased	increase	VBN	I-NP	O		677	686
levels	level	NNS	I-NP	O		687	693
of	of	IN	B-PP	O		694	696
resistance	resistance	NN	B-NP	O		697	707
to	to	TO	B-PP	O		708	710
penicillins	penicillin	NNS	B-NP	B-protein		711	722
much	much	RB	B-ADJP	O		723	727
less	less	JJR	I-ADJP	O		728	732
for	for	IN	B-PP	O		733	736
individual	individual	JJ	B-NP	O		737	747
cells	cell	NNS	I-NP	O		748	753
of	of	IN	B-PP	O		754	756
H. influenzae	H._influenzae	NNP	B-NP	O		757	770
than	than	IN	B-PP	O		771	775
for	for	IN	B-PP	O		776	779
those	those	DT	B-NP	O		780	785
of	of	IN	B-PP	O		786	788
Escherichia coli	Escherichia_coli	NNP	B-NP	O		789	805
.	.	.	O	O		805	806

Large	Large	JJ	B-NP	O		807	812
inocula	inocula	NN	I-NP	O		813	820
of	of	IN	B-PP	O		821	823
either	either	DT	B-NP	O		824	830
species	species	NN	I-NP	O		831	838
appeared	appear	VBD	B-VP	O		839	847
highly	highly	RB	B-ADJP	O		848	854
resistant	resistant	JJ	I-ADJP	O		855	864
.	.	.	O	O		864	865

The	The	DT	B-NP	O		866	869
unusually	unusually	RB	I-NP	O		870	879
low	low	JJ	I-NP	O		880	883
level	level	NN	I-NP	O		884	889
of	of	IN	B-PP	O		890	892
resistance	resistance	NN	B-NP	O		893	903
of	of	IN	B-PP	O		904	906
individual	individual	JJ	B-NP	O		907	917
cells	cell	NNS	I-NP	O		918	923
of	of	IN	B-PP	O		924	926
H. influenzae	H._influenzae	NNP	B-NP	O		927	940
containing	contain	VBG	B-VP	O		941	951
the	the	DT	B-NP	O		952	955
TEM	TEM	NN	I-NP	B-protein		956	959
-	-	HYPH	O	I-protein		959	960
type	type	NN	B-NP	I-protein		960	964
beta	beta	SYM	I-NP	I-protein		965	969
-	-	HYPH	I-NP	I-protein		969	970
lactamase	lactamase	NN	I-NP	I-protein		970	979
may	may	MD	B-VP	O		980	983
have	have	VB	I-VP	O		984	988
delayed	delay	VBN	I-VP	O		989	996
their	their	PRP$	B-NP	O		997	1002
emergence	emergence	NN	I-NP	O		1003	1012
or	or	CC	I-NP	O		1013	1015
recognition	recognition	NN	I-NP	O		1016	1027
,	,	,	O	O		1027	1028
and	and	CC	O	O		1029	1032
has	have	VBZ	B-VP	O		1033	1036
unresolved	unresolve	VBN	I-VP	O		1037	1047
clinical	clinical	JJ	B-NP	O		1048	1056
implications	implication	NNS	I-NP	O		1057	1069
.	.	.	O	O		1069	1070

